Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
Public ClinicalTrials.gov record NCT00102947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Phase 4 Trial to Further Evaluate the Pharmacokinetic Profile of Intravenous Daptomycin, and a Comparison of the Safety and Efficacy of Daptomycin Versus Comparator in the Treatment of Adult Patients With Renal Impairment and Complicated Skin and Skin Structure Infections Due, at Least in Part, to Gram-positive Bacteria
Study identification
- NCT ID
- NCT00102947
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Industry
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Interventions
- daptomycin (up to 14 days) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Oct 31, 2006
- Completion
- Oct 31, 2006
- Last update posted
- Jul 24, 2016
2005 – 2006
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harbor UCLA Medical Center | Torrance | California | 90509 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Joseph M. Still Research Institute | Augusta | Georgia | — | — |
| Infectious Diseases Minneapolis-LTD | Minneapolis | Minnesota | 55422 | — |
| Upstate Clinical Research Associates | Buffalo | New York | 14203 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| AllTrials Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Riverside Methodist Hospital | Columbus | Ohio | 43215 | — |
| Wright State University/Veterans Affairs Medical Center | Dayton | Ohio | 45428 | — |
| ID Clinical Research | Toledo | Ohio | 43608 | — |
| St. Luke's Hospital | Bethlehem | Pennsylvania | 19015 | — |
| The Reading Hospital and Medical Center | West Reading | Pennsylvania | 19610 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00102947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00102947 live on ClinicalTrials.gov.